Prot #CA224047: A Randomized Double-Blind Phase 2/3 Study of Relatlimab Combined with Nivolumab versus Nivolumab in Participants with Previously Untreated Metastatic or Unrsectable Melanoma
- Chandra, Sunandana (PD/PI)
Project: Research project
Project: Research project